HOMOLOGY MEDICINES INC (FIXX)

US4380831077 - Common Stock

0.9347  +0.01 (+0.77%)

After market: 0.892 -0.04 (-4.57%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to FIXX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.53. This target is 63.69% above the current price.
FIXX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about FIXX.
In the previous month the buy percentage consensus was at a similar level.
FIXX was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.931.521.531.531.58 - 62.08% 63.69% 63.69% 68.50%
Up and Down Grades
Date Firm Action Rating
2023-07-28 Baird Downgrade Outperform -> Neutral
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 Chardan Capital Maintains Buy -> Buy
2023-05-12 Credit Suisse Reiterate Neutral -> Neutral
2023-03-16 HC Wainwright & Co. Reiterate Buy
2022-11-17 Chardan Capital Maintains Buy
2022-11-11 RBC Capital Maintains Sector Perform
2022-08-31 Baird Maintains Outperform
2022-08-16 Chardan Capital Maintains Buy
2022-08-16 BTIG Maintains Buy
2022-08-16 Credit Suisse Maintains Neutral
2022-05-17 Credit Suisse Maintains Neutral
2022-04-28 Credit Suisse Initiate Neutral
2022-02-28 HC Wainwright & Co. Maintains Buy
2022-02-22 Chardan Capital Maintains Buy
2022-02-22 BTIG Maintains Buy
2022-02-22 Oppenheimer Downgrade Outperform -> Perform
2022-02-22 RBC Capital Downgrade Outperform -> Sector Perform
2022-02-22 B of A Securities Maintains Buy
2021-11-16 Chardan Capital Maintains Buy
2021-03-02 Stifel Initiate Hold